DrugPatentWatch Database Preview
Drugs in Development Information for KHK7580
» See Plans and Pricing
What is the drug development status for KHK7580?
KHK7580 is an investigational drug.
There have been 9 clinical trials for KHK7580.
The most recent clinical trial was a Phase 3 trial, which was initiated on September 1st 2015.
The most common disease conditions in clinical trials are Hyperparathyroidism, Hyperparathyroidism, Secondary, and Neoplasm Metastasis. The leading clinical trial sponsors are Kyowa Hakko Kirin Co., Ltd, Kyowa Hakko Kirin Company, Limited, and Kyowa Hakko Kirin China Pharmaceutical Co., LTD.
There are four US patents protecting this investigational drug and thirty-seven international patents.
Summary for KHK7580
| US Patents | 4 |
| International Patents | 37 |
| US Patent Applications | 4 |
| WIPO Patent Applications | 1 |
| Japanese Patent Applications | 0 |
| Clinical Trial Progress | Phase 3 (2015-09-01) |
| Vendors | 9 |
Recent Clinical Trials for KHK7580
| Title | Sponsor | Phase |
|---|---|---|
| Pharmacokinetic Study of KHK7580 in Healthy Adult Volunteers | Kyowa Hakko Kirin China Pharmaceutical Co., LTD. | Phase 1 |
| Pharmacokinetic Study of KHK7580 in Healthy Adult Volunteers | Kyowa Kirin Co., Ltd. | Phase 1 |
| Study of KHK7580 in Subjects With Secondary Hyperparathyroidism in Asia | Kyowa Hakko Kirin China Pharmaceutical Co., LTD. | Phase 3 |
Clinical Trial Summary for KHK7580
Top disease conditions for KHK7580
Top clinical trial sponsors for KHK7580
US Patents for KHK7580
| Drugname | Patent Number | Patent Title | Patent Assignee | Estimated Expiration |
|---|---|---|---|---|
| KHK7580 | Start Trial | Pharmaceutical composition containing an arylalkylamine compound | KYOWA HAKKO KIRIN CO., LTD. (Chiyoda-ku, JP) | Start Trial |
| KHK7580 | Start Trial | Arylalkylamine compound and process for preparing the same | Mitsubishi Tanabe Pharma Corporation (Osaka-Shi, JP) | Start Trial |
| KHK7580 | Start Trial | Arylalkylamine compound and process for preparing the same | Mitsubishi Tanabe Pharma Corporation (Osaka, JP) | Start Trial |
| >Drugname | >Patent Number | >Patent Title | >Patent Assignee | >Estimated Expiration |
International Patents for KHK7580
| Drugname | Country | Document Number | Estimated Expiration | Related US Patent |
|---|---|---|---|---|
| KHK7580 | China | 108135883 | 2035-10-07 | Start Trial |
| KHK7580 | European Patent Office | 3360551 | 2035-10-07 | Start Trial |
| KHK7580 | Japan | 2017071599 | 2035-10-07 | Start Trial |
| >Drugname | >Country | >Document Number | >Estimated Expiration | >Related US Patent |
